Last reviewed · How we verify
NCT05792397: Twi-TYPE
TwiFlow Thrombectomy Catheter sYstem for Acute Pulmonary Embolism (Twi-TYPE Study)
NA trial testing TwiFlow-Thrombectomy Catheter System in Acute Pulmonary Embolism in 127 participants. Not yet recruiting.
1 May 2024
Quick facts
| Lead sponsor | Morningside (Nantong) Medical Co.,Ltd |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 127 |
| Start date | 1 May 2023 |
| Primary completion | 1 May 2024 |
| Estimated completion | 1 May 2026 |
Drugs / interventions tested
- TwiFlow-Thrombectomy Catheter System
Conditions studied
- Acute Pulmonary Embolism — all drugs for Acute Pulmonary Embolism →
Sponsor
Morningside (Nantong) Medical Co.,Ltd
Who can join
Adults 18 to 75, any sex, with Acute Pulmonary Embolism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
As a multicenter prospective single-arm clinical study, the investigators plan to recruit patients with acute pulmonary intravascular embolization from nationwide multi-center hospital organizations in China. The investigators use the production of transcatheter pulmonary artery bolt system which named 'TwiFlow Thrombectomy Catheter System' developed by the MorningSide (NanTong) medical device Co., LTD. on pulmonary artery interventional therapy to evaluating the efficacy and safety of this novel system in the treatment of patients with pulmonary intravascular embolization disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05792397
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of TwiFlow-Thrombectomy Catheter System
Trials testing the same drug.
- NCT05443919 — A Clinical Trial to Evaluate the Efficacy and Safety of TwiFlow-System for Acute Pulmonary Embolism · NA · completed
Other recruiting trials for Acute Pulmonary Embolism
Currently open trials in the same condition.
- NCT07190079 — Saline Contrast Electrical Impedance Tomography Method for Diagnosis of Acute Pulmonary Embolism · recruiting
- NCT06784492 — Incorporating Healthy Living Strategies to Aid in Recovery After Acute Pulmonary Embolism · NA · recruiting
- NCT06038630 — 129Xe MRI Cardiopulmonary · Phase 2 · recruiting
- NCT06081205 — Study of Patients Admitted to a Cardiac Intensive Care Unit With Acute CardioVascular Disease · recruiting
- NCT04757129 — Changes of Cardiopulmonary Function After Thrombolysis in Patients With Pulmonary Embolism · recruiting
Other Morningside (Nantong) Medical Co.,Ltd trials
Trials by the same sponsor.
- NCT05443919 — A Clinical Trial to Evaluate the Efficacy and Safety of TwiFlow-System for Acute Pulmonary Embolism · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05792397 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Morningside (Nantong) Medical Co.,Ltd
- Last refreshed: 31 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05792397.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing